A 66-year-old womansuffering from fever and thrombophlebitis was referred to our hospital. A peripheral blood examination revealed hyperleukocytosis with 96 % blast cells and thrombocytopenia. The patient was diagnosed as having acute myeloid leukemia (AML) accompanied by disseminated intravascular coagulation (DIC). A marked decrease in protein C (PC) antigen and activity were observed. In this case, PC levels were lower than those observed in AMLwith DIC. Induction therapy for leukemia and treatment of DIC were started on the first day of hospitalization. The patient achieved complete remission, with PC antigen and activity levels normalized. (Internal Medicine 36: 595-597, 1997) 
Introduction
Clinical evidence of the role of protein C (PC) as a major antithrombotic factor arose from the observation that homozygous PCdeficiency led to fatal neonatal purpura fulminants.
Wereport an AMLpatient suffering from thrombophlebitis, and discuss the relationship between PC levels and leukemic cells.
Case Report
A 66-year-old womanwas referred to hospital for a common cold at the beginning of November 1995. Laboratory data was as follows: hemoglobin (Hb) 12.7 g/dl, white blood cell count (WBC) 8.6xlO9// (fraction unclear), and platelet count (Pit) 195xlO9//. Liver function was normal. Redness along the blood vessels appeared, together with fever, swelling, and pain throughout the right superior limb. At this time, the patient became aware of malaise in the left knee and swelling in the right lower jaw, accompanied by pain. She was referred to the department of cardiovascular surgery on November 1 3 and diagnosed with thrombophlebitis. She was treated with a continuous intravenous drip of antibiotics and heparin. Laboratory data then became as follows: WBC1 15.6xlO9//, fibrin degradation products (FDP) 40 jig/ml, and fibrinogen (Fbg) 127 mg/dl. She was referred to our department on November 27, 1995, for an examination for leukocytosis. Findings were leg edemawith redness ( Fig. 1 protein (CRP) 9.8 mg/dl, and endotoxin 73.2 pg/ml. Bone marrowwas hypercellular with 95.4%blast cells, and almost all blast cells were positive for myeloperoxidase. The patient was diagnosed as having acute myeloid leukemia (AML; FAB; M1) with multiple thrombophlebitis. Cytogenetic analysis of bone marrow cells showed a normal karyotype. Results of coagulation and fibrinolytic tests were as follows : thrombin/antithrombin III complex (TAT) >60 ng/ml, plasmin/antiplasmin complex (PAP) 10.7 jug/ml, and D-dimer (D-D) 60.1 ng/dl. A marked decrease of PC antigen at 45% and activity at 29%were observed. Thrombomodulinlevels did not change significantly, but plasminogen activator inhibitor-1 (PAI-1) and the tissue type plasminogen activator (t-PA)-PAI-l complex increased slightly. The Von Willebrand factor antigen (VWF), vascular endothelial cell marker was increased (Table 1) . Laboratory findings confirmed the clinical diagnosis of disseminated intravascular coagulation (DIC). Induction therapy was started on the first day of hospitalization with a combination of cytarabine and idarubicin hydrochloride. Intravenous gabexate mesilate (FOY) was administered for the duration of DIC. After four days, WBCdecreased to 0.6xl09// and DIC improved, but thrombophlebitis was aggravated. After additional treatment with urokinase, thrombophlebitis markedly improved. Laboratory results showed a gradual return to normal levels. The patient achieved complete remission (CR), with normalized PC, PS, and plasminogen levels (Fig. 2) .
Discussion
Hemostatic disturbances observed in patients with acute leukemia are related to changes in vascular function, damageto the megakaryocyte system, liver dysfunction, increased fibrinolysis, and DIC. The most commonhemostatic disorder is bleeding related to thrombocytopenia. Days after admission Figure 2 . Clinical course of this case. Ara C: cytarabine, DIC: disseminated intravascular coagulation, FOY: gabexate mesilate, IDA: idarubicin hydrochloride, LMWH: low molecular weight heparin, PC Ag (%): protein C antigen, UK: urokinase. DIC score is based on a modified version of the criteria established by the Japanese Ministry of Health and Welfare. In leukemia, DIC was diagnosed when DIC score was more than 4 points. fibrinolytic activity in plasma. Reports of hereditary PC deficiency and acquired PC deficiency observed in liver disease, DIC, and warfarin therapy suggest that PC plays an important role in both physiologic hemostasis and many clinical disorders characterized by thrombosis. A PClevel of 60%or less of normal can develop thromboembolic complications in patients with hereditary PC deficiencies (4). It has been reported that PCantigen and activity levels are significantly lower in active AMLpatients than in patients in remission or in normal controls. In normal subjects, mean PC antigen levels are 123.6% and activity levels are 95.5%. In active AML, these levels are 77.9% and 58.5% (5). Rodeghiero et al reported that PCantigen levels in acute leukemia are not lower in patients with DIC than in those without DIC. He suggested that patients with circulating blast cells exceeding 50x109// had significantly lower concentrations of PC antigen (2) . The cause of these low PC levels in AMLpatients is still a matter of controversy. Tornebohmet al suggest that the release of proteases from leukemic blast cells maybe responsible for the destruction of fibrinogen and other coagulation factors (3). The present case was admitted to our hospital with multiple thrombophlebitis, clinical DIC symptoms, and elevated endotoxin levels, but no signs of sepsis or liver dysfunction. PC antigen levels were 45% and activity levels 29%, which are lower than those ofAMLwith DIC. PC levels were normalized after complete remission. The patient had no hereditary hemostatic abnormalities. Thrombosis was similar to deep venous thrombosis in hereditary PC deficiency.
Hyperleukocytosis was not the cause of low PC levels, because her thrombophlebitis was observed with a normal leukocyte count. Noliver damagewas observed at admission. Although coagulation factor activities were somewhatreduced, the pattern was different from that of vitamin K deficiency. Weassume that low PC levels may result from PC consumption by thrombosis formation or DIC, but also from unknownfactors released from leukemic cells. Because coagulation and fibrinolysis studies were not performed before admission, it is difficult to define the relationships between leukemia and DVTin this case. Weassumed, however, that a low PC level may be one cause of DVTsideration. AMLwith DIC complicated by multiple thrombophlebitis and deep venous thrombosis is, in any case, extremely rare.
